Literature DB >> 15661169

Foot-and-mouth disease virus (FMDV) causes an acute disease that can be lethal for adult laboratory mice.

Francisco J Salguero1, Miguel A Sánchez-Martín, Fayna Díaz-San Segundo, Ana de Avila, Noemí Sevilla.   

Abstract

Foot-and-mouth disease virus (FMDV) is a picornavirus that causes an acute vesicular disease of cloven-hoofed animals. This virus continues to be threat to livestock worldwide with outbreaks causing severe economic losses. However, very little is known about FMDV pathogenesis, partially due to the inconveniences of working with cattle and swine, the main natural hosts of the virus. Here we demonstrate that C57BL/6 and BALB/C adult mice are highly susceptible to FMDV infection when the virus is administered subcutaneously or intraperitoneally. The first clinical signs are ruffled fur, apathy, humped posture, and wasting, which are followed by neurological signs such as hind-limb paralysis. Within 2-3 days of disease onset, the animals die. Virus is found in all major organs, indicating a systemic infection. Mice developed microvesicles near the basal layer of the epithelium, event that precedes the vesiculation characteristics of FMD. In addition, a lymphoid depletion in spleen and thymus and severe lymphopenia is observed in the infected mice. When these mice were immunized with conventional inactivated FMDV vaccine, they were protected (100% of vaccinated animals) against challenge with a lethal dose of FMDV. The data indicate that this mouse model may facilitate the study of FMDV pathogenesis, and the development of new effective vaccines for FMD.

Entities:  

Mesh:

Year:  2005        PMID: 15661169     DOI: 10.1016/j.virol.2004.11.005

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  18 in total

1.  Hidden virulence determinants in a viral quasispecies in vivo.

Authors:  Marta Sanz-Ramos; Fayna Díaz-San Segundo; Cristina Escarmís; Esteban Domingo; Noemí Sevilla
Journal:  J Virol       Date:  2008-08-20       Impact factor: 5.103

2.  Ribavirin as a curative and prophylactic agent against foot and mouth disease virus infection in C57BL/6 suckling and adult mice model.

Authors:  Patel Nikunjkumar; Ramasamy Periyasamy Tamil Selvan; Veerakyathappa Bhanuprakash
Journal:  Virusdisease       Date:  2021-10-20

3.  Attenuation of Foot-and-Mouth Disease Virus by Engineered Viral Polymerase Fidelity.

Authors:  Devendra K Rai; Fayna Diaz-San Segundo; Grace Campagnola; Anna Keith; Elizabeth A Schafer; Anna Kloc; Teresa de Los Santos; Olve Peersen; Elizabeth Rieder
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

4.  New vaccine design based on defective genomes that combines features of attenuated and inactivated vaccines.

Authors:  Teresa Rodríguez-Calvo; Samuel Ojosnegros; Marta Sanz-Ramos; Juan García-Arriaza; Cristina Escarmís; Esteban Domingo; Noemí Sevilla
Journal:  PLoS One       Date:  2010-04-29       Impact factor: 3.240

5.  Models of RNA virus evolution and their roles in vaccine design.

Authors:  Samuel Ojosnegros; Niko Beerenwinkel
Journal:  Immunome Res       Date:  2010-11-03

6.  Expression of porcine fusion protein IRF7/3(5D) efficiently controls foot-and-mouth disease virus replication.

Authors:  Lisbeth Ramírez-Carvajal; Fayna Díaz-San Segundo; Danielle Hickman; Charles R Long; James Zhu; Luis L Rodríguez; Teresa de los Santos
Journal:  J Virol       Date:  2014-07-16       Impact factor: 5.103

7.  Venezuelan equine encephalitis replicon particles can induce rapid protection against foot-and-mouth disease virus.

Authors:  Fayna Diaz-San Segundo; Camila C A Dias; Mauro P Moraes; Marcelo Weiss; Eva Perez-Martin; Gary Owens; Max Custer; Kurt Kamrud; Teresa de los Santos; Marvin J Grubman
Journal:  J Virol       Date:  2013-03-06       Impact factor: 5.103

8.  Synonymous Deoptimization of Foot-and-Mouth Disease Virus Causes Attenuation In Vivo while Inducing a Strong Neutralizing Antibody Response.

Authors:  Fayna Diaz-San Segundo; Gisselle N Medina; Elizabeth Ramirez-Medina; Lauro Velazquez-Salinas; Marla Koster; Marvin J Grubman; Teresa de los Santos
Journal:  J Virol       Date:  2015-11-18       Impact factor: 5.103

9.  Targeting of Aberrant αvβ6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells.

Authors:  Lynsey M Whilding; Ana C Parente-Pereira; Tomasz Zabinski; David M Davies; Roseanna M G Petrovic; Y Vincent Kao; Shobhit A Saxena; Alex Romain; Jose A Costa-Guerra; Shelia Violette; Hiroaki Itamochi; Sadaf Ghaem-Maghami; Sabari Vallath; John F Marshall; John Maher
Journal:  Mol Ther       Date:  2017-01-04       Impact factor: 11.454

Review 10.  Laboratory animal models to study foot-and-mouth disease: a review with emphasis on natural and vaccine-induced immunity.

Authors:  Mohammed Habiela; Julian Seago; Eva Perez-Martin; Ryan Waters; Miriam Windsor; Francisco J Salguero; James Wood; Bryan Charleston; Nicholas Juleff
Journal:  J Gen Virol       Date:  2014-07-07       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.